Generation Bio Co. (GBIO)
NASDAQ: GBIO · Real-Time Price · USD
5.59
-0.02 (-0.36%)
Jan 30, 2026, 1:10 PM EST - Market open
Generation Bio Co. Market Cap
Generation Bio Co. has a market cap or net worth of $37.73 million as of January 30, 2026. Its market cap has decreased by -35.81% in one year.
Market Cap
37.73M
Enterprise Value
-25.66M
1-Year Change
-35.81%
Ranking
Category
Stock Price
$5.59
Market Cap Chart
Since June 12, 2020, Generation Bio Co.'s market cap has decreased from $1.07B to $37.73M, a decrease of -96.48%. That is a compound annual growth rate of -44.78%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 29, 2026 | 37.86M | -1.08% |
| Dec 31, 2025 | 38.27M | -45.94% |
| Dec 31, 2024 | 70.80M | -35.06% |
| Dec 29, 2023 | 109.03M | -53.31% |
| Dec 30, 2022 | 233.53M | -41.89% |
| Dec 31, 2021 | 401.89M | -68.88% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Jun 12, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Lisata Therapeutics | 40.31M |
| Actinium Pharmaceuticals | 40.24M |
| Atara Biotherapeutics | 40.09M |
| Passage Bio | 39.38M |
| NextCure | 38.98M |
| OnKure Therapeutics | 38.61M |
| TuHURA Biosciences | 38.35M |
| Anebulo Pharmaceuticals | 37.39M |